Company Filing History:
Years Active: 2019
Title: Yu-Chih Yang: Innovator in Vaccine Development
Introduction
Yu-Chih Yang is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of vaccine development, particularly in the fight against avian influenza. His innovative work has led to the creation of a unique vaccine composition that combines various viral components to enhance immunogenic response.
Latest Patents
Yang holds a patent for a "Bird flu vaccine combination comprising virus-like particles and novel adjuvants." This vaccine composition includes a therapeutically effective amount of an influenza virus-like particle (VLP) that comprises influenza M1, M2, hemagglutinin (HA), and neuraminidase (NA) proteins. Additionally, it incorporates Foot-and-mouth disease virus (FMDV) capsid protein VP3, recombinant FMDV VP3 (rVP3), VP3 peptide, or SUMO VP3, along with alum. The patent also outlines the use of this vaccine composition in the manufacture of a medicament aimed at inducing an immunogenic response in subjects in need.
Career Highlights
Yang is affiliated with Academia Sinica, a prestigious research institution in Taiwan. His work at Academia Sinica has positioned him as a key figure in the field of immunology and vaccine research. His innovative approaches and dedication to scientific advancement have garnered recognition within the academic community.
Collaborations
Yang has collaborated with notable colleagues, including Shu-Mei Liang and Pei-wen Hsiao. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of their research in vaccine development.
Conclusion
Yu-Chih Yang's contributions to vaccine innovation, particularly in the development of a bird flu vaccine, highlight his role as a leading inventor in the field. His work not only advances scientific knowledge but also has the potential to improve public health outcomes.